Holen Sie sich die Stockscreener-App
36.06
3.14%
-1.17
Handel nachbörslich:
36.06
Conmed Corp Aktie (CNMD) Neueste Nachrichten
Clip Applicator Market Will Generate Booming Growth - openPR.com
(CNMD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
CONMED Corp stock (US2074101013): focus on growth after latest quarterly results - AD HOC NEWS
CONMED Corporation Announces Results of 2026 Annual Meeting, Amended By-Laws, and Director Compensation Updates - Minichart
Conmed appoints two directors to board effective July 1 - Investing.com
Celine Martin and Jeff Mirviss join ConMed board; Kimberly Lockwood named interim controller - TradingView
New CONMED (NYSE: CNMD) directors, bylaw changes and 2026 vote outcomes - Stock Titan
J&J and Boston Scientific veterans join CONMED's board - Stock Titan
CONMED Corp stock (US2074101013): shares react to Q1 2026 results and updated full-year outlook - AD HOC NEWS
Is the Options Market Predicting a Spike in CONMED Stock? - Yahoo Finance UK
Oppenheimer Asset Management Inc. Has $1.27 Million Stock Holdings in CONMED Corporation $CNMD - MarketBeat
Does CONMED (CNMD) Refocusing Away From Gastroenterology Clarify Its Long-Term Surgical Growth Story? - Yahoo Finance
Assessing CONMED (CNMD) Valuation After A Mixed Stretch In Recent Share Performance - Yahoo Finance
Is CONMED Corporation (CNMD) A Good Stock To Buy Now? - Yahoo Finance
CNMD Q1 Deep Dive: GI Exit Refocuses Growth on Core Surgical Platforms - Yahoo Finance
CONMED (NYSE:CNMD) Stock Rating Lowered by Wall Street Zen - MarketBeat
Healthcare Momentum Story Meets NYSE Composite Trends - Kalkine Media
CONMED (NYSE:CNMD) Price Target Lowered to $39.00 at Wells Fargo & Company - MarketBeat
CNMD SEC FilingsConmed Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Conmed (CNMD) Q1 2026 Earnings Transcript - AOL.com
CONMED (NYSE:CNMD) Price Target Lowered to $40.00 at JPMorgan Chase & Co. - MarketBeat
CONMED Corp 1Q 2026: Revenue $317M, EPS $0.45— 10-Q Summary - TradingView
CONMED (NYSE: CNMD) boosts Q1 2026 profit as margins expand - Stock Titan
CONMED Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up - Yahoo Finance
Conmed Corp (CNMD) Q1 2026 Earnings Call Highlights: Navigating Challenges and Capitalizing on ... By GuruFocus - Investing.com Canada
CONMED Q1 Earnings Call Highlights - MarketBeat
CONMED (NYSE:CNMD) Releases Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
CONMED Corporation (NYSE:CNMD) Beats Q1 Estimates and Raises Revenue Guidance, Shares Steady - ChartMill
Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
CONMED ($CNMD) Releases Q1 2026 Earnings - Quiver Quantitative
Conmed (CNMD) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
CONMED Q1 2026 slides: organic growth rises as GI exit weighs - Investing.com
Earnings call transcript: CONMED beats Q1 2026 forecasts, stock dips - Investing.com
Vanguard reports 1.62M shares in CONMED (NASDAQ: CNMD) as of 03/31/2026 - Stock Titan
CONMED’s (NYSE:CNMD) Q1 CY2026 Sales Beat Estimates - Barchart.com
Conmed: Q1 Earnings Snapshot - marketscreener.com
Q1 2026: CONMED (NYSE: CNMD) lifts 2026 sales outlook, EPS $0.45 - Stock Titan
Medical device maker CONMED cut sales but raised its 2026 forecast - Stock Titan
CONMED Corporation Announces First Quarter 2026 Financial Results - Yahoo Finance
Vanguard Portfolio Management (CNMD) reports 2.12M shares; 6.87% stake - Stock Titan
CONMED earnings on deck: Can AirSeal stabilize amid pressure? By Investing.com - Investing.com Canada
CONMED earnings on deck: Can AirSeal stabilize amid pressure? - Investing.com
Here's why you should retain CONMED stock in your portfolio now - MSN
CONMED Earnings: What To Look For From CNMD - Yahoo Finance
CONMED (CNMD) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
1.27%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):